Thromb Haemost 1996; 76(01): 029-033
DOI: 10.1055/s-0038-1650517
Original Article
Schattauer GmbH Stuttgart

Hereditary Macrothrombocytopenia and Pregnancy

Albert Altès
1   The Departments of Obstetrics and Gynaecology Hospital de la Santa Creu I Sant Pau de Barcelona, Spain
,
Nuria Pujol-Moix
1   The Departments of Obstetrics and Gynaecology Hospital de la Santa Creu I Sant Pau de Barcelona, Spain
,
Eduardo Muñiz-Diaz
The Hemotherapy Service, Hospital de la Santa Creu I Sant Pau de Barcelona, Spain
,
Pedro Madoz
The Hemotherapy Service, Hospital de la Santa Creu I Sant Pau de Barcelona, Spain
,
Juan Parra
2   Haematology, Hospital de la Santa Creu I Sant Pau de Barcelona, Spain
,
Jordi Fontcuberta
1   The Departments of Obstetrics and Gynaecology Hospital de la Santa Creu I Sant Pau de Barcelona, Spain
› Author Affiliations
Further Information

Publication History

Received: 09 October 1995

Accepted after resubmission15 March 1996

Publication Date:
10 July 2018 (online)

Preview

Summary

Introduction. Hereditary macrothrombocytopenias (HM) are a group of infrequent disorders characterized by hereditary giant platelets. Little has been published about the course of these diseases during pregnancy and delivery. Subjects and methods. Forty consecutive thrombocytopenic pregnant women were studied. Platelet count, mean platelet volume and blood smear examination were performed. Platelet antibodies were studied by immunofluorescence. Familial study, bleeding time, ultrastructural platelet examination, a von Willebrand disease screening and aggregation tests were carried out when HM was suspected. Results. Four cases of HM were diagnosed. Giant platelets were observed in all cases, with the typical ultrastructural pattern. Dohle-like cytoplasmic inclusions in granulocytes were observed in one case. Platelet antibodies were detected in only one case. No prophylactic measures to prevent haemorrhage were adopted, and all patients underwent vaginal deliveries. Haemorrhagic events were absent in both mothers and children. Conclusions. The prevalence of HM in pregnant trombocytopenic women is higher than assumed. Prophylactic treatment should be avoided in the absence of a history of haemorrhagic complications and obstetrical risk factors.